Table 1.
Sp Interacting with PA | Microbial/Host Response | Potential Implications on Disease | Ref(s). |
---|---|---|---|
Gram-positives | ↑ lytic activity by PA ↓ Gram+ in vivo models |
PA more toxic in co-infections with Gram+ | [114] |
↑ pyocyanin production by PA | PA mechanisms of dominance | [115] | |
S. aureus | Co-infection strains less competitive than mono-infection strains | Adaptation to coexistence in the lung | [116] |
PA induces bronchial epithelial cells to produce phospholipase, sPLA2-IIA | Manipulation of host immune response, enhanced survival of PA, and killing of SA and other Gram+ | [117] | |
PA EPS can affect mixed species biofilm architecture | Proximity of SA and PA in mixed biofilms | [118] | |
↑ PA siderophore production Lysis of SA |
Iron competition LasA protease |
[112] [119,120] |
|
PA LPS inactivation mutations ↓ production of PA LPS in anoxia |
Reduced recognition by immune system, persistence Immune evasion |
[112] [112] |
|
↑ PA swimming motility in anoxia | Reseeding of infection in lung | [17] | |
S. maltophilia | Co-colonise the CF airway | Opportunity to interact | [121] |
↓ SM growth ↑ PA biofilm |
Altered virulence and persistence | [18] [111] |
|
↓ Adhesion of PA to CFBE | Evasion of immune system and persistence | [18] | |
Streptococci spp. | ↓ SMG growth—PA competition for iron ↓ S. anginosus growth and biofilm formation ↑ Strep spp. biofilm formation—hijacks PA EPS ↓ PA viability—Strep H2O2 production |
Pathogen dominance and persistence Altered virulence and persistence Persistence Strep beneficial to host |
[122] [123] [124,125] [126] |
Burkholderia cepacia complex | ↓ PA virulence factors | Altered virulence | [127] |
PA enhances Bcc virulence | Altered virulence | [128] | |
↓ PA growth in vivo | Altered persistence | [129] | |
Reduced growth of Bcc and PA | Competition beneficial to host? | [130] | |
Co-infection ↑ inflammatory markers | Increased host inflammation | [19] | |
A. fumigatus | Co-colonise the CF airway | Opportunity to interact in airway | [131] |
Co-colonised patients—↓ lung function, ↑ hospitalisations, exacerbations and Abx usage | Poorer disease outcome | [16] | |
PA SNs stimulate AF growth | Increased AF abundance in co-infections * | [131] | |
Metacaspases from Pa SNs inhibit and damage AF biofilms | Reduced AF abundance in co-infections | [132] | |
↑ elastase production by PA in presence of AF | More damaging pathology | [133] | |
SNs from co-cultures more toxic to epithelial cells lines | More damaging pathology | [133] | |
Mutually antagonistic | Competition beneficial to host? | [134] | |
Gliotoxin produced by AF reduces PA biofilm | Competition beneficial to host? | [134] | |
Co-infections cause altered inflammatory response | Evasion of the immune system and persistence | [134] | |
PA dirhamnolipids induce AF ECM production | Inhibits AF growth and facilitates PA binding | [135] | |
PA phenazines inhibit AF growth by direct contact | Reduced AF abundance in co-infections | [136] | |
Subinhibitory concentrations of PA phenazines can promote AF growth | Increased AF abundance in co-infections * | [136] | |
Iron competition | Reduced AF abundance in co-infections | [137,138] | |
Development of PA SCVs | Reduced AF abundance in co-infections | [139] | |
Expression of QS molecules | Reduced AF abundance in co-infections | [135,140,141,142] | |
C. albicans | PA expressed LPS inhibits CA biofilm formation and hyphal development | Reduced CA abundance and virulence in co-infections | [143] |
PA QS molecule, 3-oxo-C12HSL | Reduced CA abundance in co-infections | [144] | |
PA 2-heptyl-3-hydroxyl-4-quinolone | Reduced CA abundance in co-infections | [145] | |
CA secreted Farnesol reduces PA pyocyanin Farnesol inhibits PA haemolysin Farnesol inhibits PA swarming motility |
PA less virulent | [146] | |
PA less virulent | [147] | ||
PA less virulent | [144] | ||
CA secreted tyrosol inhibits PA haemolysin and protease production | PA less virulent | [147] |
PA = P. aeruginosa, SA = S. aureus, SM = S. maltophilia, AF = A. fumigatus, CA = C. albicans, Bcc = Burkholderia cepacia complex, SMG = Streptococcus milleri group, SNs = supernatants, EPS = exopolysaccharide, LPS = lipopolysaccharide, CFBE = cystic fibrosis bronchial epithelial cells, ECM = extracellular matrix, Abx = antibiotics, QS = quorum sensing, SCVs = small colony variants. * contradictory findings.